PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
2022.22%
Net income growth above 1.5x VET's 334.21%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-7.74%
Both reduce yoy D&A, with VET at -11.68%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-300.00%
Negative yoy deferred tax while VET stands at 123.83%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
173.91%
Slight usage while VET is negative at -27.77%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-131.37%
AR is negative yoy while VET is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
606.19%
AP growth of 606.19% while VET is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
173.91%
Some yoy usage while VET is negative at -27.77%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-84.21%
Both negative yoy, with VET at -170.43%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-8.87%
Negative yoy CFO while VET is 18.34%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-15.34%
Both yoy lines negative, with VET at -119.42%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
87.44%
Acquisition spending well above VET's 70.88%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
166.67%
Less 'other investing' outflow yoy vs. VET's 980.90%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-10.35%
We reduce yoy invests while VET stands at 17.22%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
99.81%
Debt repayment above 1.5x VET's 14.08%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.